Third Generation Ventricular Assist Device: Mid‐Term Outcomes of the HeartWare HVAD in Pediatric Patients

Publisher： John Wiley & Sons Inc

E-ISSN： 1525-1594|42|2|141-147

ISSN： 0160-564x

Source： ARTIFICIAL ORGANS, Vol.42, Iss.2, 2018-02, pp. : 141-147

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Systemic or Endoventricular Thrombolysis to Treat HeartWare Left Ventricle Assist Device Thrombosis: A Clinical Dilemma

By  

ARTIFICIAL ORGANS, Vol. 39, Iss. 6, 2015-06 ,pp. : 526-529

John Wiley & Sons Inc

Access to resources Recommend Favorite

Numerical Analysis of Blood Damage Potential of the HeartMate II and HeartWare HVAD Rotary Blood Pumps

By  

ARTIFICIAL ORGANS, Vol. 39, Iss. 8, 2015-08 ,pp. : 651-659

John Wiley & Sons Inc

Access to resources Recommend Favorite

Exercise Capacity and Functional Performance in Heart Failure Patients Supported by a Left Ventricular Assist Device at Discharge From Inpatient Rehabilitation

By  

ARTIFICIAL ORGANS, Vol. 42, Iss. 1, 2018-01 ,pp. : 22-30

John Wiley & Sons Inc

Access to resources Recommend Favorite

Robust mid-term power generation management

By Guigues V.  

Optimization, Vol. 58, Iss. 3, 2009-04 ,pp. : 351-371

Taylor & Francis Ltd

Access to resources Recommend Favorite

Treatment of an Intercostal Left Ventricular Assist Device Prolapse by Upgrading From HeartMate II to HeartMate 3

By  

ARTIFICIAL ORGANS, Vol. 42, Iss. 2, 2018-02 ,pp. : 242-244

John Wiley & Sons Inc

Access to resources Recommend Favorite